ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1404

Effects Of Smoking On Joint Physiology In Men and Mice

Caroline Ospelt1, Giovanni Camici2, Anna Engler3, Christoph Kolling4, Renate E. Gay5, Beat A. Michel6 and Steffen Gay1, 1Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland, 2Institute of Physiology, University of Zurich, Zurich, Switzerland, 3Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 4Schultess Clinic, Zurich, Switzerland, 5Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland, 6Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Smoking is a major risk factor for the development of anti-citrullinated protein antibodies positive rheumatoid arthritis (RA) in individuals who carry shared epitope alleles. The molecular mechanisms that confer this risk are however not clarified up to now. Even more it is not clear whether smoking can affect joint physiology directly or via indirect immune mechanisms that cross-react with joint structures. We analyzed synovial tissues of human smokers and of mice exposed to cigarette smoke as well as in vitro stimulated RA synovial fibroblasts (SF) to find effects of smoking on joint physiology.

Methods:

Synovial tissues were obtained from smoking (n=5) and non smoking (n=6) RA patients undergoing joint replacement surgery and from mice exposed to cigarette smoke (n=6) or room air (n=8) or) in a whole body exposure chamber for 3 weeks. RASFs were incubated with 5% cigarette smoke extract (CSE) (n=7). Changes in gene expression were detected using whole genome microarrays and verified with Real-time PCR and immunoblotting.

Results:

Gene expression analysis and functional classification showed that CSE treatment in vitro leads to a broad activation of the chaperone and heat shock protein system. This finding could be confirmed in vivo, where we found a significant increase in the expression of the HSP40 family members, DnaJB4 (1.8 fold) and DnaJC6 (2.2 fold) in synovial tissues of human smokers as well as in mice exposed to cigarette smoke (DnaJB4 2.2 fold, DnaJC6 2.7 fold). Furthermore, in human synovial tissues, but not in mice, smokers had 3.5 fold higher levels of Hsp70 and 3.2 fold higher levels of HspB8 similar to what was seen in in vitro stimulations.

The list of CSE altered genes also contained a ligand of the activating immune receptor NKG2D. This ligand, MICB, together with other ligands of this receptor namely MICA, ULBP2 and ULBP3 was significantly increased after CSE in vitro. MICA (2.6 fold) and MICB (2.1 fold) were also significantly higher in synovial tissues of smokers compared to non-smokers. In addition the mouse homologue of these ligands, H60 was 2.9 fold higher expressed in joints of smoke exposed mice.

Conclusion:

Our results clearly show that systemic effects of cigarette smoke include changes in joints. Since synovial fluid is passively filtrated from the blood, it is feasible to assume that cigarette smoke components in the blood can reach the synovial fluid and influence local tissue physiology. Therefore smoking can increase the risk to develop RA by locally changing gene expression in the synovium.


Disclosure:

C. Ospelt,
None;

G. Camici,
None;

A. Engler,
None;

C. Kolling,
None;

R. E. Gay,
None;

B. A. Michel,
None;

S. Gay,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effects-of-smoking-on-joint-physiology-in-men-and-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology